Infasurf

Infasurf Indications/Uses

Manufacturer:

ONY Biotech

Distributor:

Transmedic
Full Prescribing Info
Indications/Uses
Prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS and for the treatment ("rescue") of premature infants who develop RDS. Infasurf decreases the incidence of RDS, mortality due to RDS, and air leaks associated with RDS.
Prophylaxis therapy at birth for premature infants <29 weeks of gestational age at significant risk for RDS. Infasurf prophylaxis should be administered as soon as possible, preferably within 30 min after birth.
For infants ≤72 hrs of age with RDS (confirmed by clinical and radiologic findings) and requiring endotracheal intubation.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in